ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Smoking Cessation Interventions in Dental Clinic Smokers

This study is currently recruiting patients.

Sponsored by: National Institute of Dental and Craniofacial Research (NIDCR)
Memorial Sloan-Kettering Cancer Center
New York University School of Medicine
Information provided by: National Institute of Dental and Craniofacial Research (NIDCR)

Purpose

The major goal of this study is to see if dentist delivered cessation advice and risk counseling about the effects of tobacco in the mouth will enhance the motivation to quit smoking.

Condition Treatment or Intervention Phase
Smoking cessation
Motivational interviewing
Cancer risk
Tobacco
 Behavior: Motivational interviewing/Personalized risk counseling
Phase III

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study

Official Title: Personalized Risk Feedback in Dental Clinic Smokers

Further Study Details: 

Expected Total Enrollment:  1260

Study start: November 2002;  Study completion: March 2006

Despite the health hazards of tobacco use, approximately 47 million Americans continue to use tobacco. The primary care dental team has a credible, central role in providing smoking cessation advice and information concerning the oral health effects of tobacco use. Given that unrealistic optimism regarding one's tobacco-related illness risk attenuates smokers' motivation to quit, providing patients with information regarding the personal impact of tobacco on their health is likely to enhance minimal contact smoking cessation interventions by increasing quitting motivation. The overall goal of this project is to test the effect of personalized risk communication on short and long-term smoking cessation outcomes among dental patients in a large, multi-ethnic public dental clinic. Personalized Risk Communication involves two components: a) level of tobacco exposure (alveolar carbon monoxide level); and b) tobacco-related oral damage (through dental hygienist examination of teeth and oral mucosa). The study uses a prospective, experimental design to assess the effect of this intervention on smoking cessation, health and smoking-related cognitions at approximately 3 and 12 months. Participants are randomized to one of three smoking cessation treatment conditions: 1) Standard Care only (SC) receives standard care dentist-provided smoking cessation advice, assistance and follow-up; 2) Standard Care + Dental Hygienist-provided Motivational Counseling (SC+MC) receives standard care plus motivational smoking cessation counseling provided by a trained dental hygienist, and 3) Standard Care + Dental Hygienist-provided Motivational Counseling + Personalized Risk Communication (SC+MC+PRC) receives standard care plus motivational counseling and personalized risk communication. The overarching aim is to test the effect of personalized risk communication on smoking cessation and to examine potential mechanisms and moderating effects of the personalized risk communication. Receiving personalized risk communication in the dental setting, especially when paired with dentist-provided minimal contact smoking cessation advice and dental hygienist-provided motivational counseling, could increase smokers' motivation for quitting, and represents an important translational, multidisciplinary strategy for tobacco-related cancer prevention

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion criteria:

Exclusion criteria:


Location and Contact Information

Jamie Ostroff, PhD      212-583-3015    ostroffj@Mskcc.org
Gustavo Cruz, DMD,MPH      212-998-9989    gdc1@nyu.edu

New York
      NYU College of Dentistry, New York,  New York,  10010,  United States; Recruiting
Jamie Ostroff, Ph.D.  212-583-3015    ostroffj@mskcc.org 
Gustavo Cruz, DMD,MPH  212-998-9989    gdc1@nyu.edu 
Jamie Ostroff, Ph.D.,  Principal Investigator

More Information

Study ID Numbers:  NIDCR-13750
Record last reviewed:  October 2004
Record first received:  October 8, 2003
ClinicalTrials.gov Identifier:  NCT00070798
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act